<p id="p001">Immune checkpoint inhibitors have improved clinical outcomes associated with
numerous cancers, but high-grade, immune-related adverse events can occur, particularly …

By impairing both function and survival, the severe reduction in oxygen availability associated
with high-altitude environments is likely to act as an agent of natural selection. We used …

We introduce quanTIseq, a method to quantify the fractions of ten immune cell types from bulk
RNA-sequencing data. quanTIseq was extensively validated in blood and tumor samples …

Therapeutic antibodies blocking programmed death-1 and its ligand (PD-1/PD-L1) induce
durable responses in a substantial fraction of melanoma patients. We sought to determine …

Background The importance of cross-talk between a cancer and its microenvironment has
been increasingly recognized. We hypothesized that mutational inactivation of the tumor-…

In this trans-ethnic multi-omic study, we reinterpret the genetic architecture of blood
pressure to identify genes, tissues, phenomes and medication contexts of blood pressure …

Introduction The pattern of exhaled breath volatile organic compounds represents a
metabolic biosignature with the potential to identify and characterize lung cancer. Breath …

Clonal hematopoiesis of indeterminate potential (CHIP) is a common form of age-related
somatic mosaicism that is associated with significant morbidity and mortality. CHIP mutations …

Purpose: Cancer-associated fibroblasts (CAF) have been implicated as potential mediators
of checkpoint immunotherapy response. However, the extensive heterogeneity of these cells …

Checkpoint inhibitors produce durable responses in numerous metastatic cancers, but
immune-related adverse events (irAEs) complicate and limit their benefit. IrAEs can affect organ …